| Key features and details | |
| Cat. No. | MABL-2253 | 
| Name | Anti-LGI1 mAbs | 
| Clone No. | AFD- N283/7 | 
| From | Recombinant Antibody | 
| Isotype | Engineer antibody | 
| Application | IB, ICC, ELISA, IF, IHC | 
| Species Reactivity | Rat, Human, Mouse | 
| Basic Information | |
| Specificity | This antibody is specific for mouse LGI1 and cross-reacts with rat and human LGI1. It does not cross-react with LGI2, LGI3, or LGI4. | 
| Alternative Name | Leucine-Rich Glioma-Inactivated 1; Leucine rich glioma inactivated 1; Epitempin-1; EPITEMPIN; EPT; ETL1; ADLTE; ADPAEF; ADPEAF; IB1099; UNQ775/PRO1569 | 
| UniProt | Q9JIA1 | 
| Immunogen | The original antibody was generated by immunizing Balb/c mice with fusion protein amino acids 37-113 (LRRNT domain and first LRR repeat) of mouse LGI1. | 
| Application Notes | This antibody can be used for IB, ICC, and IHC (RRID: AB_2877432). Independently, it was used in an IF assay (Hivert et al., 2019; PMID: 30598502), an ELISA (Kornau et al., 2020; PMID: 31900946), and an IHC assay (Kozar, 2022; DOI: 10.7488/era/2379). | 
| Antibody First Published | Hivert et al. ADAM22 and ADAM23 modulate the targeting of the Kv1 channel-associated protein LGI1 to the axon initial segment. J Cell Sci. 2019 Jan 16;132(2):jcs219774. doi: 10.1242/jcs.219774. PMID:30598502 | 
| Note on publication | The original publication investigates the role of ADAM22 and ADAM23 in modulating the targeting of the Kv1 channel-associated protein LGI1 to the axon initial segment. | 
| COA Information (For reference only, actual COA shall prevail) | |
| Size | 100 μg Purified antibody. | 
| Concentration | 1 mg/ml. | 
| Purification | Protein A affinity purified | 
| Buffer | PBS with 0.02% Proclin 300. | 
| Concentration | 1 mg/ml. | 
| Storage Recommendation | Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at - 20⁰C. | 

 
  



